{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:00:50Z","timestamp":1770058850273,"version":"3.49.0"},"reference-count":43,"publisher":"Scientific Scholar","issue":"1-2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Since the beginning of the year, the deadly coronavirus pandemic, better known as coronavirus disease 2019 (COVID-19), brought the entire world to an unprecedented halt. In tandem with the global scenario, researchers in India are actively engaged in the conduct of clinical research to counter the pandemic. This review attempts to provide a comprehensive overview of the COVID-19 research in India including design aspects, through the clinical trials registered in the Clinical Trials Registry - India (CTRI) till June 5, 2020. One hundred and twenty two registered trials on COVID-19 were extracted from the CTRI database. These trials were categorized into modern medicine (n=42), traditional medicine (n=67) and miscellaneous (n=13). Of the 42 modern medicine trials, 28 were on repurposed drugs, used singly (n=24) or in combination (n=4). Of these 28 trials, 23 were to evaluate their therapeutic efficacy in different severities of the disease. There were nine registered trials on cell- and plasma-based therapies, two phytopharmaceutical trials and three vaccine trials. The traditional medicine trials category majorly comprised Ayurveda (n=45), followed by homeopathy (n=14) and others (n=8) from Yoga, Siddha and Unani. Among the traditional medicine category, 31 trials were prophylactic and 36 were therapeutic, mostly conducted on asymptomatic or mild-to-moderate COVID-19 patients. This review would showcase the research being conducted on COVID-19 in the country and highlight the research gaps to steer further studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_2556_20","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T06:54:26Z","timestamp":1638773666000},"page":"26-63","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Emerging trends from COVID-19 research registered in the Clinical Trials Registry - India"],"prefix":"10.25259","volume":"153","author":[{"given":"M. Vishnu Vardhana","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohua","family":"Maulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulsi","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashmin","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R6-4-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2040206618764483","article-title":"Nucleosides for the treatment of respiratory RNA virus infections","volume":"26","author":"Jordan","year":"2018","journal-title":"Antivir Chem Chemother"},{"key":"R7-4-20241212","doi-asserted-by":"crossref","first-page":"ofaa130","DOI":"10.1093\/ofid\/ofaa130","article-title":"Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)","volume":"7","author":"Pastick","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R8-4-20241212","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R10-4-20241212","first-page":"357027","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemother Res Pract"},{"key":"R11-4-20241212","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors","volume":"99","author":"Sisk","year":"2018","journal-title":"J Gen Virol"},{"key":"R12-4-20241212","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/ijmr.IJMR_585_20","article-title":"Perspectives for repurposing drugs for the coronavirus disease 2019","volume":"151","author":"Cherian","year":"2020","journal-title":"Indian J Med Res"},{"key":"R13-4-20241212","doi-asserted-by":"crossref","first-page":"1316326","DOI":"10.1155\/2016\/1316326","article-title":"Clinical outcome of a novel anti-CD6 biologic itolizumab in patients of psoriasis with comorbid conditions","volume":"2016","author":"Singh","year":"2016","journal-title":"Dermatol Res Pract"},{"key":"R14-4-20241212","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2014.01.897","article-title":"Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study","volume":"71","author":"Krupashankar","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R15-4-20241212","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R16-4-20241212","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijtb.2018.08.004","article-title":"Potential of adjunctive Mycobacterium w (MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis","volume":"65","author":"Chahar","year":"2018","journal-title":"Indian J Tuberc"},{"key":"R17-4-20241212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/lungindia.lungindia_242_20","article-title":"Safety of an immunomodulator Mycobacterium w in COVID-19","volume":"37","author":"Sehgal","year":"2020","journal-title":"Lung India"},{"key":"R18-4-20241212","doi-asserted-by":"crossref","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: Melatonin as a potential adjuvant treatment","volume":"250","author":"Zhang","year":"2020","journal-title":"Life Sci"},{"key":"R19-4-20241212","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jcp.29036","article-title":"Immunoregulatory role of melatonin in cancer","volume":"235","author":"Moradkhani","year":"2020","journal-title":"J Cell Physiol"},{"key":"R20-4-20241212","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"R21-4-20241212","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad spectrum antiviral agent niclosamide and its therapeutic potential","volume":"6","author":"Xu","year":"2020","journal-title":"ACS Infect Dis"},{"key":"R23-4-20241212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R24-4-20241212","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai","year":"2020","journal-title":"Hypertens Res"},{"key":"R25-4-20241212","doi-asserted-by":"crossref","first-page":"17015","DOI":"10.1038\/cddiscovery.2017.15","article-title":"Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation","volume":"3","author":"Mittra","year":"2017","journal-title":"Cell Death Discov"},{"key":"R26-4-20241212","doi-asserted-by":"crossref","first-page":"e0229017","DOI":"10.1371\/journal.pone.0229017","article-title":"Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice","volume":"15","author":"Mittra","year":"2020","journal-title":"PLoS One"},{"key":"R27-4-20241212","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1021\/jf010869g","article-title":"Sodium copper chlorophyllin: in vitro digestive stability and accumulation by Caco-2 human intestinal cells","volume":"50","author":"Ferruzzi","year":"2002","journal-title":"J Agric Food Chem"},{"key":"R28-4-20241212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/iub.1251","article-title":"The wonders of 2-deoxy-D-glucose","volume":"66","author":"Xi","year":"2014","journal-title":"IUBMB Life"},{"key":"R31-4-20241212","first-page":"6","article-title":"Quantitative determination of gallic acid from methanolic extract of Cocculus hirsutus using HTPLC","volume":"7","author":"Meena","year":"2016","journal-title":"Int J Pharm Bio Arch"},{"key":"R32-4-20241212","first-page":"950","article-title":"Thymoquinone: an emerging natural drug with a wide range of medical applications","volume":"17","author":"Khader","year":"2014","journal-title":"Iran J Basic Med Sci"},{"key":"R33-4-20241212","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Transfus"},{"key":"R36-4-20241212","first-page":"593","article-title":"Strategies for vaccine development of COVID-19","volume":"36","author":"Yang","year":"2020","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"R37-4-20241212","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"key":"R38-4-20241212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12688\/wellcomeopenres.10544.1","article-title":"Tuberculosis control in postcolonial South India and beyond: Fractured sovereignties in international health, 1948-1960","volume":"2","author":"Neelakantan","year":"2017","journal-title":"Wellcome Open Res"},{"key":"R41-4-20241212","first-page":"36","article-title":"Ayurveda: a historical perspective and principles of the traditional healthcare system in India","volume":"7","author":"Mishra","year":"2001","journal-title":"Altern Ther Health Med"},{"key":"R42-4-20241212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0257-7941.107344","article-title":"Tinospora cordifolia: One plant, many roles","volume":"31","author":"Saha","year":"2012","journal-title":"Anc Sci Life"},{"key":"R43-4-20241212","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0974-7788.64405","article-title":"Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi). validation of the Ayurvedic pharmacology through experimental and clinical studies","volume":"1","author":"Upadhyay","year":"2010","journal-title":"Int J Ayurveda Res"},{"key":"R44-4-20241212","first-page":"334","article-title":"Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review","volume":"5","author":"Mishra","year":"2000","journal-title":"Altern Med Rev"},{"key":"R45-4-20241212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40781-017-0156-2","article-title":"Nitric oxide induced by Indian ginseng root extract inhibits infectious Bursal Disease virus in chicken embryo fibroblasts in vitro","volume":"60","author":"Ganguly","year":"2018","journal-title":"J Anim Sci Technol"},{"key":"R46-4-20241212","first-page":"186864","article-title":"A review on antibacterial, antiviral, and antifungal activity of curcumin","volume":"2014","author":"Moghadamtousi","year":"2014","journal-title":"Biomed Res Int"},{"key":"R48-4-20241212","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/0974-8520.92579","article-title":"Protective effect of Yashtimadhu (Glycyrrhiza glabra) against side effects of radiation\/chemotherapy in head and neck malignancies","volume":"32","author":"Das","year":"2011","journal-title":"Ayu"},{"key":"R51-4-20241212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/biom9050161","article-title":"Chyawanprash: A traditional Indian bioactive health supplement","volume":"9","author":"Sharma","year":"2019","journal-title":"Biomolecules"},{"key":"R52-4-20241212","first-page":"9","article-title":"Life event, stress and illness","volume":"15","author":"Salleh","year":"2008","journal-title":"Malays J Med Sci"},{"key":"R53-4-20241212","first-page":"100","article-title":"Self-reported mental health predicts acute respiratory infection","volume":"114","author":"Maxwell","year":"2015","journal-title":"WMJ"},{"key":"R54-4-20241212","first-page":"10","article-title":"The effects of stress and meditation on the immune system, human microbiota, and epigenetics","volume":"31","author":"Househam","year":"2017","journal-title":"Adv Mind Body Med"},{"key":"R55-4-20241212","doi-asserted-by":"crossref","first-page":"e100903","DOI":"10.1371\/journal.pone.0100903","article-title":"The effects of mind-body therapies on the immune system: Meta-analysis","volume":"9","author":"Morgan","year":"2014","journal-title":"PLoS One"},{"key":"R56-4-20241212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/ijoy.IJOY_43_18","article-title":"Changes in lung function measures following Bhastrika Pranayama (Bellows Breath) and running in healthy individuals","volume":"12","author":"Budhi","year":"2019","journal-title":"Int J Yoga"},{"key":"R57-4-20241212","doi-asserted-by":"crossref","first-page":"138859","DOI":"10.1016\/j.scitotenv.2020.138859","article-title":"Overview of Covid-19; its prevention and management in the light of Unani medicine","volume":"728","author":"Nikhat","year":"2020","journal-title":"Sci Total Environ"},{"key":"R58-4-20241212","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaim.2019.04.002","article-title":"Concepts of body constitution in traditional Siddha texts: A literature review","volume":"10","author":"Muthiah","year":"2019","journal-title":"J Ayurveda Integr Med"},{"key":"R59-4-20241212","first-page":"160","article-title":"Integrating homoeopathy in health systems","volume":"77","author":"Poitevin","year":"1999","journal-title":"Bull World Health Organ"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_2556_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:06:03Z","timestamp":1751497563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/emerging-trends-from-covid-19-research-registered-in-the-clinical-trials-registry-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_2556_20","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}